Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-function of alpha1-adrenergic receptors.

Dianne M Perez1

  • 1Department of Molecular Cardiology, NB5, The Cleveland Clinic Foundation, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Perezd@ccf.org

Biochemical Pharmacology
|October 21, 2006
PubMed
Summary

This review explores alpha(1)-adrenergic receptor structure and function, detailing how drug design evolved from the Easson-Stedman hypothesis to subtype-specific targeting for improved therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

α<sub>1A</sub>-Adrenergic Receptor as a Target for Neurocognition: Cautionary Tale from Nicergoline and Quinazoline Non-Selective Blockers.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α<sub>1A</sub>-Adrenergic Receptor.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

A PAM of the α<sub>1A</sub>-Adrenergic receptor rescues biomarker, long-term potentiation, and cognitive deficits in Alzheimer's disease mouse models without effects on blood pressure.

Current research in pharmacology and drug discovery·2023
Same author

α<sub>1</sub>-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer's Disease.

International journal of molecular sciences·2023
Same author

Characterization of a novel positive allosteric modulator of the α<sub>1A</sub>-Adrenergic receptor.

Current research in pharmacology and drug discovery·2022
Same author

Pharmacological characterization of the α<sub>2A</sub>-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency.

Journal of receptor and signal transduction research·2022

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • The Easson-Stedman hypothesis guided early alpha(1)-adrenergic receptor drug design.
  • Key structural features for receptor interaction include a protonated amine, beta-hydroxyl, and hydrogen-bonding aromatic ring.

Purpose of the Study:

  • To review the historical development and current understanding of alpha(1)-adrenergic receptor subtype structure-function relationships.
  • To highlight advancements in drug design enabled by receptor cloning and subtype discovery.

Main Methods:

  • Literature review of historical and contemporary research on alpha(1)-adrenergic receptors.
  • Analysis of structure-activity relationships and receptor-ligand interactions.
  • Exploration of emerging concepts like allosterism and agonist trafficking.

Related Experiment Videos

Main Results:

  • Chemical modifications revealed essential pharmacophoric elements for alpha(1)-adrenergic receptor ligands.
  • Discovery of three alpha(1)-adrenergic receptor subtypes facilitated subtype-selective drug design.
  • Differences in ligand-binding pockets between alpha(1)- and beta-adrenergic receptors allow for greater selectivity.

Conclusions:

  • Understanding alpha(1)-adrenergic receptor subtypes is crucial for developing targeted therapeutics.
  • Future drug design can leverage allosterism and agonist trafficking for enhanced efficacy and reduced side effects.